Jasper Therapeutics, Inc.
JSPR
Revenue
0.00
0.000.00%
-Assets
113.93M
▼-12.03M▼-9.55%
3 Months ChangeLiabilities
13.62M
▲886.00k▲6.96%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-15
Form 8-K
ID: 0001213900-24-087394
2024-08-13
Form 10-Q
ID: 0001213900-24-067897
2024-06-20
Form 8-K
ID: 0001213900-24-053982
2024-06-12
Form 8-K
ID: 0001213900-24-051891
2024-05-14
Form 10-Q
ID: 0001213900-24-042805
2024-03-04
Form 8-K
ID: 0001213900-24-019249
2024-02-06
Form 8-K
ID: 0001213900-24-010267
2024-01-04
Form 8-K
ID: 0001213900-24-000980
2024-01-02
Form 8-K
ID: 0001213900-24-000056
2023-12-20
Form 8-K
ID: 0001213900-23-097100